https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Tue, 18 Mar 2025 12:15:47 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png https://pharmatimes.com 32 32 232894315 https://pharmatimes.com/appointments/taylor-boyd/ Tue, 18 Mar 2025 12:14:42 +0000 https://pharmatimes.com/?p=103002 Abzena has appointed Taylor Boyd as Chief Business Officer

]]> 103002 https://pharmatimes.com/news/ucl_research_team_bags_3-5m_mrc_grant_1187887/ Wed, 01 Mar 2017 11:03:00 +0000 https://pharmatimes.com/uncategorized/ucl_research_team_bags_3-5m_mrc_grant_1187887/ A research group from UCL's Centre for Rheumatology has been awarded a £3.5 million grant from the Medical Research Council (MRC) to advance the development of a novel treatment for anti-phospholipid syndrome (APS) based on UK life sciences group Abzena's proprietary conjugation technology.

]]> 60868